US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

iShares Genomics Immunology and Healthcare ETF

41.65

+0.01000.02%

Post-market: 41.650.00000.00%19:59 EDT

Volume:230.10K

Turnover:9.56M

Market Cap:301.96M

PE:- -

High:42.04

Open:41.84

Low:41.25

Close:41.64

52wk High:42.97

52wk Low:23.90

Shares:7.25M

Float Shares:7.25M

Volume Ratio:0.80

T/O Rate:3.17%

Dividend:0.28

Dividend Rate:0.67%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Moderna Slips After Citi Downgrades to 'sell'

Moderna appoints Juan Andres as COO

Satellos announces enrollment completed for BASECAMP

Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”

Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains

Moderna Adds Chief Operating Officer Role as Company Expands into Oncology

THOMSON REUTERS

Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website

THOMSON REUTERS

Moderna Appoints Juan Andres as Chief Operating Officer

Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup

Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60

THOMSON REUTERS

Sagimet Biosciences reports results from Phase 3 ASC40-304 OLE clinical trial

Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026

Moderna sinks 4% to $195.42 after Citi downgrades to Sell

Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains

DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years

Moderna Inc. Stock Climbs 3.1%, Outperforms Peers

Liver safety concerns emerge for Bristol Myers’ admilparant, says Wells Fargo

Twist Bioscience (TWST) Gets a Buy from Leerink Partners

NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease

CSPC Launches Phase Ib Trial of Obesity Biologic JMT206 in China

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IDNA/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IDNA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","market":"US","secType":"STK","nameCN":"iShares Genomics Immunology and Healthcare ETF","latestPrice":41.65,"timestamp":1790971200000,"preClose":41.64,"halted":0,"volume":230097,"hourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.00024015369836690706,"floatShares":7250000,"shares":7250000,"eps":0,"marketStatus":"Market Closed","change":0.01,"latestTime":"10-02 16:00:00 EDT","open":41.84,"high":42.04,"low":41.25,"amount":9561511.483608,"amplitude":0.018972,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":41.64,"sharesOutstanding":5100000,"nav":41.483661,"aum":309053274.45,"dividendRate":0.006706,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":41.8183,"preClose":41.64,"latestTime":"09:24 EDT","volume":122,"amount":5156.36538,"timestamp":1790947482007,"change":0.1783,"changeRate":0.004282,"amplitude":0.028206},"postHourTrading":{"tag":"盘后","latestPrice":41.65,"preClose":41.65,"latestTime":"19:59 EDT","volume":3094,"amount":128861.28,"timestamp":1790985596008,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8041356708242576,"impliedVol":0.1282,"impliedVolPercentile":0.243},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IDNA\",,,,,undefined,":{"symbol":"IDNA","floatShares":7250000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8041356708242576,"shares":7250000,"dividePrice":0.2793,"high":42.04,"amplitude":0.018972,"preClose":41.64,"low":41.25,"week52Low":23.9,"pbRate":"--","week52High":42.97,"institutionHeld":0,"latestPrice":41.65,"eps":0,"divideRate":0.006706,"volume":230097,"delay":0,"ttmEps":0,"open":41.84,"prevYearClose":26.19,"prevWeekClose":41.77,"prevMonthClose":42.32,"prevQuarterClose":42.32,"fiveDayClose":41.77,"twentyDayClose":40.29,"sixtyDayClose":34.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IDNA\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"IDNA","amount":0.125421,"announcedDate":"2026-06-12","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2025-12-16","symbol":"IDNA","amount":0.155456,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2025-06-16","symbol":"IDNA","amount":0.152909,"announcedDate":"2025-06-13","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-16","defaultRemindTime":1750080600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-20","payableDate":"2025-06-16","currency":"USD","dateTimestamp":1750046400000,"payDate":"2025-06-20"},{"date":"2024-12-17","symbol":"IDNA","amount":0.11105,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"IDNA","amount":0.11144,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"iShares Genomics Immunology and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IDNA\",market:\"US\",,,undefined,":[{"executeDate":"2019-12-16","recordDate":"2019-12-17","paymentDate":"2019-12-20","value":0.237063,"currency":"USD"},{"executeDate":"2020-06-15","recordDate":"2020-06-16","paymentDate":"2020-06-19","value":0.083667,"currency":"USD"},{"executeDate":"2020-12-14","recordDate":"2020-12-15","paymentDate":"2020-12-18","value":0.036209,"currency":"USD"},{"executeDate":"2021-06-10","recordDate":"2021-06-11","paymentDate":"2021-06-16","value":0.052145,"currency":"USD"},{"executeDate":"2021-12-13","recordDate":"2021-12-14","paymentDate":"2021-12-17","value":0.256358,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IDNA\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IDNA\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2671982209","title":"Moderna Slips After Citi Downgrades to 'sell'","url":"https://stock-news.laohu8.com/highlight/detail?id=2671982209","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671982209?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:39","pubTimestamp":1790768392,"startTime":"0","endTime":"0","summary":"BUZZ-Moderna slips after Citi downgrades to 'sell'** Biotech firm Moderna'sMRNA.Oshares fall 6.2% to $190.89 premarket** Brokerage Citigroup downgrades MRNA to \"sell\" from \"neutral\", says optimism related to cancer drugs has already been priced in** Brokerage says the stock's re-rating reflects potential expansion into multiple tumor types and unrealistic implied sales expectations** Citi says stock's current valuation is unjustifiable, with a negatively skewed risk-reward profile** Citi raises price target on MRNA to $80 from $60, representing a near 61% downside to co's last close of $203.46** As of last close, MRNA shares up roughly seven-fold this year","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nL6N45M0O9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","MRNY","BK4585","BK4568","LGHT","BK4551","BK4534","IDNA","MRNA","BK4532","GNOM","BK4139","BK4548","BK4501","BK4533","MRNX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206715","title":"Moderna appoints Juan Andres as COO","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206715","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206715?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766930,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) announced the addition of a COO role to support the increasing scale and diversification of the Company. The new role comes as Moder...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-appoints-juan-andres-as-coo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-appoints-juan-andres-as-coo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MRNY","BK4588","LGHT","BK4534","IDNA","BK4585","GNOM","BK4501","BK4568","BK4533","BK4532","MRNA","BK4551","WDNA","MRNX","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671726206","title":"Satellos announces enrollment completed for BASECAMP","url":"https://stock-news.laohu8.com/highlight/detail?id=2671726206","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671726206?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766924,"startTime":"0","endTime":"0","summary":"Satellos (MSLE) Bioscience announced that enrollment has been completed for BASECAMP, the company’s Phase 2 clinical trial evaluating forazapadin f...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/satellos-announces-enrollment-completed-for-basecamp-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/satellos-announces-enrollment-completed-for-basecamp-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HYLG","BK4139","IDNA","NVIB","GDOC","MEDX","MSLE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206085","title":"Citi Downgrades Moderna Stock after 222% Rally, Calls Oncology Expectations “Unrealistic”","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206085","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206085?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:15","pubTimestamp":1790766915,"startTime":"0","endTime":"0","summary":"Citigroup downgraded Moderna, Inc. ($MRNA) from Neutral/High Risk to Sell/High Risk after the biotech stock’s sharp two-month rally, arguing that o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/citi-downgrades-moderna-stock-after-222-rally-calls-oncology-expectations-unrealistic?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","WDNA","MRNA","BK4548","BK4532","BK4501","BK4585","MRNX","BK4568","LGHT","NVIB","MRNY","BK4551","IDNA","XBIX","BK4534","BK4139","BK4533","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206126","title":"Citi Tells Investors It's Time to Sell Moderna After 600%-Plus Stock Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206126","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206126?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:12","pubTimestamp":1790766720,"startTime":"0","endTime":"0","summary":"Biotech can't generate the revenue that investors expect, says Wall Street firmModerna was the target of a sell recommendation by Citi.After rallying almost seven-fold this year, Citi is now advising ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["REGN","LU0114720955.EUR","LU0823434740.USD","BK4548","WDNA","LU2362540622.SGD","LU0823434583.USD","LU0889565916.HKD","ISBC","LU2362541273.HKD","BK4534","BBH","BK4139","LU0320765992.SGD","LU0053666078.USD","LU0058720904.USD","BK4532","LU0882574055.USD","BK4211","GNOM","LU1974910355.USD","LU2089984988.USD","MRNY","LU2106854487.HKD","LU2324357040.USD","LGHT","BK4568","BK4533","IBB","LU2362541513.USD","TBXU","IBBQ","LU0823416689.USD","MRNA","IDNA","BK4588","MRNX","LU1917777945.USD","BK4585","LU2023250504.SGD","LU0289739699.SGD","LU0109394709.USD","BK4551","BK4501","LU2237438978.USD","LU2468319806.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206332","title":"Moderna Adds Chief Operating Officer Role as Company Expands into Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206332","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206332?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766162,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0LB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["WDNA","GNOM","BK4533","BK4548","IDNA","MRNA","MRNX","MRNY","BK4534","BK4551","BK4532","BK4568","BK4501","BK4139","BK4588","BK4585","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671063402","title":"Moderna: Juan Andres to Return to Moderna as Chief Operating Officer - Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2671063402","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671063402?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766162,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0LB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNY","BK4551","BK4548","BK4585","IDNA","WDNA","MRNX","BK4532","BK4588","BK4534","GNOM","LGHT","BK4568","BK4533","BK4139","MRNA","BK4501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671206369","title":"Moderna Appoints Juan Andres as Chief Operating Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2671206369","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671206369?lang=en_us&edition=fundamental","pubTime":"2026-09-30 19:02","pubTimestamp":1790766128,"startTime":"0","endTime":"0","summary":"Moderna appoints Juan Andres as chief operating officerModerna created a Chief Operating Officer role as it scales operations for a broader oncology push.Juan Andres will return as Chief Operating Off","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDL2q7MsY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","BK4588","LGHT","BK4534","IDNA","BK4585","GNOM","BK4501","BK4568","BK4533","BK4532","MRNA","BK4551","WDNA","MRNX","BK4548","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671720531","title":"Moderna Price Target Raised to $80.00/Share from $60.00 by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2671720531","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671720531?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:32","pubTimestamp":1790764320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MRNA/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","BK4585","BK4501","GNOM","LGHT","BK4532","BK4139","BK4548","BK4588","MRNA","MRNX","MRNY","IDNA","WDNA","BK4551","BK4568","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671342203","title":"Moderna : Citigroup Cuts to Sell from Neutral; Raises Target Price to $80 from $60","url":"https://stock-news.laohu8.com/highlight/detail?id=2671342203","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671342203?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:16","pubTimestamp":1790763366,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nFWN45M0N5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MRNA","IDNA","BK4533","WDNA","BK4548","LGHT","BK4532","MRNX","MRNY","BK4585","BK4534","BK4551","BK4139","BK4501","BK4568","GNOM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203699","title":"Sagimet Biosciences reports results from Phase 3 ASC40-304 OLE clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203699","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671203699?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:10","pubTimestamp":1790763034,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced positive 52-week results from the Phase 3 ASC40-304 OLE clinical trial of denifanstat in patients with moderat...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-reports-results-from-phase-3-asc40-304-ole-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-reports-results-from-phase-3-asc40-304-ole-clinical-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MEDX","SGMT","NVIB","GDOC","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671087702","title":"Sagimet Announces Positive Full 52-Week Results from License Partner Ascletis' Phase 3 Open-Label Extension Clinical Trial of Denifanstat in Acne Presented at EADV 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2671087702","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671087702?lang=en_us&edition=fundamental","pubTime":"2026-09-30 18:00","pubTimestamp":1790762400,"startTime":"0","endTime":"0","summary":"In the Phase 3 open-label extension clinical trial (OLE), patients with moderate to severe acne received denifanstat for up to 52 weeks, including prior placebo patientsDenifanstat showed progressive ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/30/3371663/0/en/sagimet-announces-positive-full-52-week-results-from-license-partner-ascletis-phase-3-open-label-extension-clinical-trial-of-denifanstat-in-acne-presented-at-eadv-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HYLG","MEDX","SD","GDOC","IGA","NVIB","IDNA","BK4213"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671208459","title":"Moderna sinks 4% to $195.42 after Citi downgrades to Sell","url":"https://stock-news.laohu8.com/highlight/detail?id=2671208459","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671208459?lang=en_us&edition=fundamental","pubTime":"2026-09-30 17:55","pubTimestamp":1790762117,"startTime":"0","endTime":"0","summary":"05:50 EDT Moderna (MRNA) sinks 4% to $195.42 after Citi downgrades to Sell Published first on TheFly – the ultimate source for real-time, market-mo...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-sinks-4-to-195-42-after-citi-downgrades-to-sell-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-sinks-4-to-195-42-after-citi-downgrades-to-sell-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","MRNY","BK4585","BK4568","LGHT","BK4551","BK4534","IDNA","MRNA","BK4532","GNOM","BK4139","BK4548","BK4501","BK4533","MRNX","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171282700","title":"Hong Kong Stocks Midday Review: Hang Seng Index Slips 0.04% in Morning Session, CRO-Related Shares Lead Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=1171282700","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171282700?lang=en_us&edition=fundamental","pubTime":"2026-09-30 12:07","pubTimestamp":1790741227,"startTime":"0","endTime":"0","summary":"The Hang Seng Index fell 0.04%, down 10 points, to 24,513 points; the Hang Seng Tech Index declined 0.15%.Morning trading turnover in Hong Kong stocks reached HK$88.7 billion.mRNA-related shares...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1831875114.USD","LU0181495838.USD","BK1191","03067","02202","BK4534","09115","002821","MRNX","BK1524","603127","BK4585","BK4139","LU0326950275.SGD","01787","LU0140636845.USD","BK4532","HHImain","HSTECH","BK1137","07500","513600","BK4533","07226","02723","BK1178","06127","BK1590","06185","LU0244354667.USD","BK1544","BK1594","09088","03423","07552","01860","BK1198","BK1576","BK1586","HSImain","LU0828237940.HKD","BK4551","HSI","LGHT","HK0000306701.USD","06802","688185","LU1188198961.HKD","03417","01548","BK1592","00625","HTImain","03419","BK1206","MCHmain","GNOM","BK4588","02833","07200","HK0000306685.HKD","83115","300347","600547","IE0034224299.USD","LU0463099449.HKD","MRNY","URNJ","BK1515","03032","BK1141","BK1521","BK1507","BK1574","03088","03037","BK4501","07300","BK1161","03347","02362","06821","03115","BK4548","82800","BK4568","HK0000320223.HKD","03033","02837","BK1583","01164","02800","WDNA","MRNA","09067","BK1518","BK1240","BK1613","000002","HK0000320264.USD","BK1555","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671942228","title":"DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for the VIASKIN® Peanut Patch in Children Aged 4-7 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2671942228","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671942228?lang=en_us&edition=fundamental","pubTime":"2026-09-30 06:29","pubTimestamp":1790720940,"startTime":"0","endTime":"0","summary":"Chtillon, France, September 29, 2026 DBV Technologies Announces Submission of Biologics License Application to U.S. FDA for theVIASKIN Peanut Patch in Children Aged 4-7 Years  TheBLAis supportedbyther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3371452/0/en/dbv-technologies-announces-submission-of-biologics-license-application-to-u-s-fda-for-the-viaskin-peanut-patch-in-children-aged-4-7-years.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GDOC","BK4588","HYLG","NVIB","MEDX","BK4585","LABU","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671324755","title":"Moderna Inc. Stock Climbs 3.1%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2671324755","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671324755?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:35","pubTimestamp":1790714100,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 3.1% to $203.46 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.1% to 26,797.54 and Dow Jones Industrial Average falling 0.3% to 51,349.92.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $202.67, which the company achieved on September 25th.The stock outperformed some of its peers, as Johnson & Johnson fell 1.6% to $267.57, Pfizer Inc. remained unchanged, and Gilead Sciences Inc. fell 0.61% to $151.28.Trading volume totaled 13.1 million, compared to the 50-day average of 19.2 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","LU2324357040.USD","LU1057294990.SGD","LU0965509010.AUD","BMED","LU0861579265.USD","GNOM","MRNY","WDNA","LGHT","LU0882574055.USD","LU0965509283.SGD","LU1674673428.USD","LU1839511570.USD","BIB","IE00BZ1G4Q59.USD","LU1934455277.USD","LU0965508806.USD","BK4585","LU2089984988.USD","TBXU","LU1934455194.USD","LU0320765992.SGD","BK4533","LU1430594728.SGD","LU1571399168.USD","TMED","BK4551","LU0889565916.HKD","IBB","LU2468319806.SGD","BK4578","MRNX","BBH","MEDI","BK4534","MRNA","IE00BKVL7J92.USD","BK4550","LU0289739699.SGD","GILD","LU0859254822.USD","LU0122379950.USD","LU1066053197.SGD","IE00B3T34201.USD","LU0058720904.USD","LU1674673691.USD","IBBQ","LU0114720955.EUR","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671054242","title":"Liver safety concerns emerge for Bristol Myers’ admilparant, says Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2671054242","media":"TIPRANKS","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671054242?lang=en_us&edition=fundamental","pubTime":"2026-09-30 04:10","pubTimestamp":1790712632,"startTime":"0","endTime":"0","summary":"Wells Fargo says admilparant protocol documents on EU clinical trials suggest liver safety issues in blinded Phase 3 data. While the firm says “we ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/liver-safety-concerns-emerge-for-bristol-myers-admilparant-says-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/liver-safety-concerns-emerge-for-bristol-myers-admilparant-says-wells-fargo-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","IE00B19Z3581.USD","HYLG","LU0310799852.SGD","LU1668664300.SGD","BK4585","MYE","KBWB","PGF","BK4559","IE000M9KFDE8.USD","LU1791807156.HKD","LU1894683348.USD","BMED","IE00B7SZLL34.SGD","LU2361045086.USD","LU0320765489.SGD","LU1894683264.USD","BK4504","LU1506573853.SGD","LU0048573561.USD","LU1280957306.USD","BK4126","LU0154236417.USD","LU0251131958.USD","IE00B19Z3B42.SGD","LU0175139822.USD","LU0211327993.USD","LU0267386448.USD","LU0942090050.USD","LU0289960550.SGD","BK4588","LU0980610538.SGD","FTXO","NVIB","LU0310800379.SGD","BK4582","LU0162691827.USD","LU0211328371.USD","LU0052756011.USD","LU0029864427.USD","LU1363072403.SGD","LU1074936037.SGD","LU0971096721.USD","TFNS","IYF","LU2236285917.USD","MEDX","LU1035773651.USD","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671221213","title":"Twist Bioscience (TWST) Gets a Buy from Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2671221213","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671221213?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:55","pubTimestamp":1790686553,"startTime":"0","endTime":"0","summary":"Leerink Partners analyst Puneet Souda maintained a Buy rating on Twist Bioscience today and set a price target of $190.00. Souda covers the Healthc...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/twist-bioscience-twst-gets-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/twist-bioscience-twst-gets-a-buy-from-leerink-partners-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","ARKG","IDNA","GNOM","WDNA","BK4139","BK4588","TWST"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671949211","title":"NewAmsterdam Pharma Doses First Participant in Phase 2b SPINOZA Trial Evaluating Obicetrapib in Preclinical Alzheimer’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2671949211","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671949211?lang=en_us&edition=fundamental","pubTime":"2026-09-29 20:00","pubTimestamp":1790683200,"startTime":"0","endTime":"0","summary":"- SPINOZA is studying obicetrapib in adults with biomarker evidence suggestive of preclinical Alzheimer’s disease who do not have noticeable memory or functional symptoms- - The study will evaluate ch","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/29/3370754/0/en/newamsterdam-pharma-doses-first-participant-in-phase-2b-spinoza-trial-evaluating-obicetrapib-in-preclinical-alzheimer-s-disease.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","BK4080","NVIB","CDR","BMED","HYLG","GDOC","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671213179","title":"CSPC Launches Phase Ib Trial of Obesity Biologic JMT206 in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2671213179","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671213179?lang=en_us&edition=fundamental","pubTime":"2026-09-29 18:07","pubTimestamp":1790676452,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group ( ($HK:1093) ) has shared an update. CSPC Pharmaceutical Group has initiated a Phase Ib clinical trial in China for JMT20...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-trial-of-obesity-biologic-jmt206-in-china?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cspc-launches-phase-ib-trial-of-obesity-biologic-jmt206-in-china?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GDOC","NVIB","MEDX","HYLG","IDNA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}